Correlative Biomarker Study in Patients With Myeloproliferative Disorders

CompletedOBSERVATIONAL
Enrollment

592

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

July 20, 2018

Study Completion Date

July 20, 2018

Conditions
Myeloproliferative DiseaseMyelofibrosisIdiopathic MyelofibrosisEssential ThrombocythemiaPolycythemia Vera
Trial Locations (22)

10029

Icahn School of Medicine at Mount Sinai, New York

10065

Weill Cornell Medical College, New York

11632

Ospedale San Martino Genova, Genova

18201

Geisinger Cancer Center, Hazleton

19104

University of Pennsylvania, Philadelphia

20057

Georgetown University, Washington D.C.

21201

University of Maryland, Baltimore

27100

San Matteo Hospital, Pavia

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27705

Duke University Medical Center, Durham

30322

Emory Hospital, Atlanta

43210

Ohio State University, Columbus

60065

New York Blood Center, New York

60612

University of Illinois at Chicago, Chicago

84112

University of Utah, Salt Lake City

85259

Mayo Clinic, Scottsdale

94301

The Palo Alto Clinic, Palo Alto

M5T 2M9

Princess Margaret Cancer Centre, Toronto

Unknown

Ospedali Riuniti di Bergamo, Bergamo

University of Florence, Florence

00168

Universita Cattolica del Sacro Cuore, Rome

SE1 7EH

Guy's and St Thomas' NHS Foundation Trust, London

All Listed Sponsors
collaborator

Myeloproliferative Disorders-Research Consortium

NETWORK

collaborator

National Cancer Institute (NCI)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT00665067 - Correlative Biomarker Study in Patients With Myeloproliferative Disorders | Biotech Hunter | Biotech Hunter